Limited survival in patients with peritoneal carcinomatosis (PC) from gastric, duodenal or pancreatic cancer after tumor debulking and continuous hyperthermic peritoneal perfusion (CHPP) with cisplatin

被引：0
|
作者：
Farma, JM
Pingpank, JF
Libutti, SK
Bartlett, DL
Ohl, SC
Beresneva, T
Alexander, HR
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A817 / A817
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosis
    Cho, HK
    Lush, RM
    Bartlett, DL
    Alexander, HR
    Wu, PC
    Libutti, SK
    Lee, KB
    Venzon, DJ
    Bauer, KS
    Reed, E
    Figg, WD
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (04): : 394 - 401
  • [2] Continuous hyperthermic peritoneal perfusion (CHPP) for prevention of peritoneal recurrence of gastric cancer
    Maeta, M
    Ikeguchi, M
    Kaibara, N
    [J]. XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 361 - 364
  • [3] Limited survival in patients with carcinomatosis from foregut malignancies after cytoreduction and continuous hyperthermic peritoneal perfusion
    Farma, JM
    Pingpank, JF
    Libutti, SK
    Bartlett, DL
    Ohl, S
    Beresneva, T
    Alexander, HR
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2005, 9 (09) : 1346 - 1353
  • [4] Limited survival in patients with carcinomatosis from foregut malignancies after cytoreduction and continuous hyperthermic peritoneal perfusion
    Jeffrey M. Farma
    James F. Pingpank
    Steven K. Libutti
    David L. Bartlett
    Susan Ohl
    Tatiana Beresneva
    H. Richard Alexander
    [J]. Journal of Gastrointestinal Surgery, 2005, 9 : 1346 - 1353
  • [5] Studies on immunological changes after continuous hyperthermic peritoneal perfusion (CHPP) for gastric cancer
    Kiyozaki, H
    Kobayashi, E
    Suganuma, H
    Hata, M
    Adachi, K
    Kai, T
    Miyata, M
    [J]. PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 1413 - 1415
  • [6] Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis
    Kunisaki, Chikara
    Shimada, Hiroshi
    Akiyama, Hirotoshi
    Nomura, Masato
    Matsuda, Goro
    Otsuka, Yuichi
    Ono, Hidetaka
    Takahashi, Masazumi
    [J]. HEPATO-GASTROENTEROLOGY, 2006, 53 (69) : 473 - 478
  • [7] A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis
    Bartlett, DL
    Buell, JF
    Libutti, SK
    Reed, E
    Lee, KB
    Figg, WD
    Venzon, DJ
    Alexander, HR
    [J]. CANCER, 1998, 83 (06) : 1251 - 1261
  • [8] Lack of efficacy of prophylactic continuous hyperthermic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancer
    Kunisaki, C
    Shimada, H
    Nomura, M
    Akiyama, H
    Takahashi, M
    Matsuda, G
    [J]. SURGERY, 2002, 131 (05) : 521 - 528
  • [9] A phase I trial of continuous hyperthermic peritoneal perfusion using cisplatin in pediatric patients with carcinomatosis.
    Hayes-Jordan, A. A.
    Green, H. L.
    Anderson, P. M.
    Xiao, L.
    Hunt, K.
    Mansfield, P. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Cytoreductive surgery with continuous hyperthermic peritoneal perfusion with cisplatin (CHPP): Analysis of morbidity and mortality in 266 patients treated at a single institution
    Blansfield, Joseph
    Libutti, Steven K.
    Royal, Richard E.
    Alexander, H. richard
    Hughes, Marybeth S.
    Steinberg, Seth M.
    Ohl, Susan E.
    Beresneva, Tatiana
    Pingpank, James F.
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A877 - A878
12345